These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38684648)

  • 1. Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma.
    Li X; Pan YF; Chen YB; Wan QQ; Lin YK; Shang TY; Xu MY; Jiang TY; Pei MM; Tan YX; Dong LW; Wan XY
    Cell Death Dis; 2024 Apr; 15(4):300. PubMed ID: 38684648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
    Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically.
    Zhang X; Hu B; Sun YF; Huang XW; Cheng JW; Huang A; Zeng HY; Qiu SJ; Cao Y; Fan J; Zhou J; Yang XR
    Clin Transl Med; 2021 Feb; 11(2):e335. PubMed ID: 33634982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14-3-3η/NF-κB feedback loop.
    Qiu Y; Dai Y; Zhang C; Yang Y; Jin M; Shan W; Shen J; Lu M; Tang Z; Ju L; Wang Y; Jiao R; Xia Y; Huang G; Yang L; Li Y; Zhang J; Wong VKW; Jiang Z
    J Exp Clin Cancer Res; 2018 Dec; 37(1):321. PubMed ID: 30572915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide-induced upregulation of miR-1294 suppresses tumor growth in hepatocellular carcinoma by targeting TEAD1 and PIM1.
    Cai X; Yu L; Chen Z; Ye F; Ren Z; Jin P
    Cancer Biomark; 2020; 28(2):221-230. PubMed ID: 32280078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
    Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma.
    Thomsen MK; Skouboe MK; Boularan C; Vernejoul F; Lioux T; Leknes SL; Berthelsen MF; Riedel M; Cai H; Joseph JV; Perouzel E; Tiraby M; Vendelbo MH; Paludan SR
    Oncogene; 2020 Feb; 39(8):1652-1664. PubMed ID: 31740782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex.
    Wang HY; Zhang B; Zhou JN; Wang DX; Xu YC; Zeng Q; Jia YL; Xi JF; Nan X; He LJ; Yue W; Pei XT
    Cell Death Dis; 2019 Jun; 10(6):453. PubMed ID: 31186405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C
    Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
    Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Activation of Immunogenic Cell Death and cGAS-STING Pathway by Liver- and Mitochondria-Targeted Gold(I) Complexes for Chemoimmunotherapy of Hepatocellular Carcinoma.
    Li F; Wen Z; Wu C; Yang Z; Wang Z; Diao W; Chen D; Xu Z; Lu Y; Liu W
    J Med Chem; 2024 Feb; 67(3):1982-2003. PubMed ID: 38261008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin-Embellished Arsenic Trioxide-Loaded Polymeric Nanoparticles Enhance Tumor Accumulation and Anticancer Efficacy via Transcytosis for Hepatocellular Carcinoma Therapy.
    Huang Y; Xu Z; Wei Y; Han S; Cai X; Chen D
    AAPS PharmSciTech; 2022 Apr; 23(4):111. PubMed ID: 35411416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation.
    Zhai B; Jiang X; He C; Zhao D; Ma L; Xu L; Jiang H; Sun X
    Tumour Biol; 2015 Apr; 36(4):2323-34. PubMed ID: 25416439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RECQL4 Inhibits Radiation-Induced Tumor Immune Awakening via Suppressing the cGAS-STING Pathway in Hepatocellular Carcinoma.
    Hong W; Zhang Y; Wang S; Li Z; Zheng D; Hsu S; Zhou J; Fan J; Chen Z; Xia X; Zeng Z; Gao Q; Yu M; Du S
    Adv Sci (Weinh); 2024 Apr; 11(16):e2308009. PubMed ID: 38381090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocarrier-based delivery of arsenic trioxide for hepatocellular carcinoma therapy.
    Sun J; Cheng M; Ye T; Li B; Wei Y; Zheng H; Zheng H; Zhou M; Piao JG; Li F
    Nanomedicine (Lond); 2022 Nov; 17(26):2037-2054. PubMed ID: 36789952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Jiang H; Ma Y; Chen X; Pan S; Sun B; Krissansen GW; Sun X
    Cancer Sci; 2010 Apr; 101(4):975-83. PubMed ID: 20219070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1α Expression.
    Chen Y; Li H; Chen D; Jiang X; Wang W; Li D; Shan H
    Dig Dis Sci; 2022 Aug; 67(8):3806-3816. PubMed ID: 34383201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
    Zheng T; Yin D; Lu Z; Wang J; Li Y; Chen X; Liang Y; Song X; Qi S; Sun B; Xie C; Meng X; Pan S; Liu J; Jiang H; Liu L
    Mol Cancer; 2014 May; 13():133. PubMed ID: 24884809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2.
    Dong S; Li Z; Kong J; Wu S; Gao J; Sun W
    Int J Hyperthermia; 2022; 39(1):888-896. PubMed ID: 35848416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.